Literature DB >> 8083358

Behavioral consequences of bone marrow transplantation in the treatment of murine mucopolysaccharidosis type VII.

L Bastedo1, M S Sands, D T Lambert, M A Pisa, E Birkenmeier, P L Chang.   

Abstract

The gusmps/gusmps mouse is a model of the human lysosomal storage disease mucopolysaccharidosis type VII caused by deficient beta-glucuronidase activity. Bone marrow transplantation has been shown to correct some of their biochemical and pathological abnormalities but its efficacy in correcting their neurological functional deficits is unknown. We transplanted the neonatal gusmps/gusmps mice and their normal controls and evaluated their central nervous system function with two behavioral tests: the grooming test, a developmentally regulated and genetically based activity, and a Morris water maze test which assessed spatial learning abilities. The two transplanted groups groomed less than the normals, were unable to remember the location of an invisible platform from day to day, and were severely impaired at developing strategies to locate the platform in unfamiliar locations. The performance of both normal and mutant transplanted groups was clearly inferior to the untreated normals and, in some instances, close to or worse than the untreated mutants, even though the enzyme abnormalities of the mutants have been partially corrected. Hence, the behavioral deficits in the mutant mice were not restored to normal while similarly treated normal mice showed significant functional deterioration, indicating the detrimental consequence of this therapy in the neonatal period.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8083358      PMCID: PMC295192          DOI: 10.1172/JCI117434

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis.

Authors:  W S Sly; B A Quinton; W H McAlister; D L Rimoin
Journal:  J Pediatr       Date:  1973-02       Impact factor: 4.406

3.  Place navigation impaired in rats with hippocampal lesions.

Authors:  R G Morris; P Garrud; J N Rawlins; J O'Keefe
Journal:  Nature       Date:  1982-06-24       Impact factor: 49.962

4.  Beta-glucuronidase deficiency mucopolysaccharidosis: methods for enzymatic diagnosis.

Authors:  J H Glaser; W S Sly
Journal:  J Lab Clin Med       Date:  1973-12

5.  Decortication of rats in infancy or adulthood produced comparable functional losses on learned and species-typical behaviors.

Authors:  B Kolb; I Q Whishaw
Journal:  J Comp Physiol Psychol       Date:  1981-06

6.  Mucopolysaccharidosis type VII (beta-glucuronidase deficiency): a report of a new case and a survey of those in the literature.

Authors:  A C Sewell; J Gehler; G Mittermaier; E Meyer
Journal:  Clin Genet       Date:  1982-06       Impact factor: 4.438

7.  Sensorimotor impairments following localized kainic acid and 6-hydroxydopamine lesions of the neostriatum.

Authors:  S B Dunnett; S D Iversen
Journal:  Brain Res       Date:  1982-09-23       Impact factor: 3.252

8.  A comparison of the contributions of the frontal and parietal association cortex to spatial localization in rats.

Authors:  B Kolb; R J Sutherland; I Q Whishaw
Journal:  Behav Neurosci       Date:  1983-02       Impact factor: 1.912

9.  A behavioural analysis of spatial localization following electrolytic, kainate- or colchicine-induced damage to the hippocampal formation in the rat.

Authors:  R J Sutherland; I Q Whishaw; B Kolb
Journal:  Behav Brain Res       Date:  1983-02       Impact factor: 3.332

10.  Developments of a water-maze procedure for studying spatial learning in the rat.

Authors:  R Morris
Journal:  J Neurosci Methods       Date:  1984-05       Impact factor: 2.390

View more
  13 in total

Review 1.  Gene transfer approaches to the lysosomal storage disorders.

Authors:  J A Barranger; E O Rice; W P Swaney
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

2.  VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients.

Authors:  Pampee P Young; A Alex Hofling; Mark S Sands
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-23       Impact factor: 11.205

3.  Bone marrow transplantation prolongs life span and ameliorates neurologic manifestations in Sandhoff disease mice.

Authors:  F Norflus; C J Tifft; M P McDonald; G Goldstein; J N Crawley; A Hoffmann; K Sandhoff; K Suzuki; R L Proia
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

4.  Active site mutant transgene confers tolerance to human beta-glucuronidase without affecting the phenotype of MPS VII mice.

Authors:  W S Sly; C Vogler; J H Grubb; M Zhou; J Jiang; X Y Zhou; S Tomatsu; Y Bi; E M Snella
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

5.  Production of MPS VII mouse (Gus(tm(hE540A x mE536A)Sly)) doubly tolerant to human and mouse beta-glucuronidase.

Authors:  Shunji Tomatsu; Koji O Orii; Carole Vogler; Jeffrey H Grubb; Elizabeth M Snella; Monica Gutierrez; Tatiana Dieter; Christopher C Holden; Kazuko Sukegawa; Tadao Orii; Naomi Kondo; William S Sly
Journal:  Hum Mol Genet       Date:  2003-05-01       Impact factor: 6.150

6.  Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors.

Authors:  Andrew I Brooks; Colleen S Stein; Stephanie M Hughes; Jason Heth; Paul M McCray; Sybille L Sauter; Julie C Johnston; Deborah A Cory-Slechta; Howard J Federoff; Beverly L Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

7.  Systemic and central nervous system correction of lysosomal storage in mucopolysaccharidosis type VII mice.

Authors:  C S Stein; A Ghodsi; T Derksen; B L Davidson
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

8.  Murine mucopolysaccharidosis type VII: long term therapeutic effects of enzyme replacement and enzyme replacement followed by bone marrow transplantation.

Authors:  M S Sands; C Vogler; A Torrey; B Levy; B Gwynn; J Grubb; W S Sly; E H Birkenmeier
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

9.  Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function.

Authors:  L H O'Connor; L C Erway; C A Vogler; W S Sly; A Nicholes; J Grubb; S W Holmberg; B Levy; M S Sands
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

Review 10.  Murine mucopolysaccharidosis type VII: the impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease.

Authors:  C Vogler; M S Sands; N Galvin; B Levy; C Thorpe; J Barker; W S Sly
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.